Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.644 JPY | +0,98 % | +3,40 % | +17,05 % |
Resumen de negocios
Número de empleados: 4 144
Ventas por actividad
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Prescription Drugs
93,3
%
| 249 579 | 93,7 % | 260 235 | 93,3 % | +4,27 % |
Over-the-counter Drugs
3,8
%
| 9 780 | 3,7 % | 10 628 | 3,8 % | +8,67 % |
Medical Equipment
2,2
%
| 5 184 | 1,9 % | 6 257 | 2,2 % | +20,70 % |
Others
0,7
%
| 1 714 | 0,6 % | 1 919 | 0,7 % | +11,96 % |
Ventas por región
JPY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Japan
63,6
%
| 173 633 | 65,2 % | 177 373 | 63,6 % | +2,15 % |
EMEA
18,8
%
| 42 899 | 16,1 % | 52 513 | 18,8 % | +22,41 % |
Asia
8,6
%
| 19 813 | 7,4 % | 24 118 | 8,6 % | +21,73 % |
China
7,7
%
| 27 197 | 10,2 % | 21 546 | 7,7 % | -20,78 % |
Americas
1,3
%
| 2 715 | 1,0 % | 3 488 | 1,3 % | +28,47 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 64 | 01/04/82 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Akira Kurokawa
CHM | Chairman | 71 | 01/04/77 |
Mika Masunari
CMP | Compliance Officer | - | - |
Minori Hara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Keizo Nakada
PRN | Corporate Officer/Principal | - | - |
Ippei Kurihara
SAM | Sales & Marketing | - | - |
Tomoki Yashiki
HRO | Human Resources Officer | - | - |
Hiro Izaka
AUD | Comptroller/Controller/Auditor | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Akira Kurokawa
CHM | Chairman | 71 | 01/04/77 |
Kanoko Oishi
BRD | Director/Board Member | 63 | 01/06/15 |
Noboru Kotani
BRD | Director/Board Member | 67 | 24/06/22 |
Yutaro Shintaku
BRD | Director/Board Member | 68 | 01/06/17 |
Director/Board Member | 69 | 01/06/18 | |
Takeshi Ito
CEO | Chief Executive Officer | 64 | 01/04/82 |
Tamie Minami
BRD | Director/Board Member | 65 | 24/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 363 996 254 | 341 047 590 ( 93,70 %) | 786 780 ( 0,2162 %) | 93,70 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
3 746 000 | 0.75% | 54 179 110 $ | |
EISAI CO., LTD. 0.32% | 949 500 | 0.32% | 39 231 403 $ |
737 469 | 0.20% | 7 144 356 $ | |
373 800 | 0.17% | 5 867 161 $ | |
259 040 | 0.00% | 2 600 029 $ | |
SEIKAGAKU CORPORATION 0.73% | 415 600 | 0.73% | 1 964 899 $ |
TOHO HOLDINGS CO., LTD. 0.09% | 69 050 | 0.09% | 1 655 550 $ |
QD LASER, INC. 1.06% | 444 480 | 1.06% | 1 417 909 $ |
SUZUKEN CO., LTD. 0.05% | 42 226 | 0.05% | 1 250 962 $ |
VITAL KSK HOLDINGS, INC. 0.25% | 128 474 | 0.25% | 1 006 631 $ |
Información de la empresa
Santen Pharmaceutical Co., Ltd.
Grand Front Osaka Tower A, 25/F 4-20 Ofuka-cho
530-8552, Osaka
+81 6 7664 8621
http://www.santen.co.jpEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Santen Oy
Santen Oy Pharmaceuticals: MajorHealth Technology Santen Oy engages in the development, research, manufacture and marketing of pharmaceuticals, over-the-counter products, and medical devices. It specializes in ophthalmic pharmaceuticals. The company was founded on February 28, 1997 and is headquartered in Tampere, Finland. |
Pharmaceuticals: Major
|
Santen Pharmaceutical Spain SL
Santen Pharmaceutical Spain SL Medical DistributorsDistribution Services Part of Santen Pharmaceutical Co., Ltd., Santen Pharmaceutical Spain SL wholesales pharmaceutical products. The company is based in Las Rozas, Spain. |
Medical Distributors
|
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,05 % | 3761,08 M | |
+40,73 % | 739 mil M | |
+32,83 % | 598 mil M | |
-6,30 % | 353 mil M | |
+15,15 % | 318 mil M | |
+4,05 % | 285 mil M | |
+15,00 % | 240 mil M | |
+9,78 % | 210 mil M | |
-5,52 % | 206 mil M | |
+6,17 % | 164 mil M |
- Bolsa de valores
- Acciones
- Acción 4536
- Empresa Santen Pharmaceutical Co., Ltd.